TY - JOUR
T1 - Zika Virus Neuropathogenesis
T2 - The Different Brain Cells, Host Factors and Mechanisms Involved
AU - Komarasamy, Thamil Vaani
AU - Adnan, Nur Amelia Azreen
AU - James, William
AU - Balasubramaniam, Vinod R.M.T.
N1 - Funding Information:
We thank the reviewer for critical comments and suggestions. We would also like to thank the school and administration staff of Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia for their continuous support to this project and lab members of Infectious Disease Laboratory for critically reading this review.
Publisher Copyright:
Copyright © 2022 Komarasamy, Adnan, James and Balasubramaniam.
PY - 2022/3/16
Y1 - 2022/3/16
N2 - Zika virus (ZIKV), despite being discovered six decades earlier, became a major health concern only after an epidemic in French Polynesia and an increase in the number of microcephaly cases in Brazil. Substantial evidence has been found to support the link between ZIKV and neurological complications in infants. The virus targets various cells in the brain, including radial glial cells, neural progenitor cells (NPCs), astrocytes, microglial and glioblastoma stem cells. It affects the brain cells by exploiting different mechanisms, mainly through apoptosis and cell cycle dysregulation. The modulation of host immune response and the inflammatory process has also been demonstrated to play a critical role in ZIKV induced neurological complications. In addition to that, different ZIKV strains have exhibited specific neurotropism and unique molecular mechanisms. This review provides a comprehensive and up-to-date overview of ZIKV-induced neuroimmunopathogenesis by dissecting its main target cells in the brain, and the underlying cellular and molecular mechanisms. We highlighted the roles of the different ZIKV host factors and how they exploit specific host factors through various mechanisms. Overall, it covers key components for understanding the crosstalk between ZIKV and the brain.
AB - Zika virus (ZIKV), despite being discovered six decades earlier, became a major health concern only after an epidemic in French Polynesia and an increase in the number of microcephaly cases in Brazil. Substantial evidence has been found to support the link between ZIKV and neurological complications in infants. The virus targets various cells in the brain, including radial glial cells, neural progenitor cells (NPCs), astrocytes, microglial and glioblastoma stem cells. It affects the brain cells by exploiting different mechanisms, mainly through apoptosis and cell cycle dysregulation. The modulation of host immune response and the inflammatory process has also been demonstrated to play a critical role in ZIKV induced neurological complications. In addition to that, different ZIKV strains have exhibited specific neurotropism and unique molecular mechanisms. This review provides a comprehensive and up-to-date overview of ZIKV-induced neuroimmunopathogenesis by dissecting its main target cells in the brain, and the underlying cellular and molecular mechanisms. We highlighted the roles of the different ZIKV host factors and how they exploit specific host factors through various mechanisms. Overall, it covers key components for understanding the crosstalk between ZIKV and the brain.
KW - animal models
KW - Guillain-Barre syndrome
KW - host factors
KW - immune response
KW - microcephaly
KW - mitochondrial damage
KW - neuroinflammation
KW - Zika virus
UR - https://www.scopus.com/pages/publications/85127480187
U2 - 10.3389/fimmu.2022.773191
DO - 10.3389/fimmu.2022.773191
M3 - Review Article
C2 - 35371036
AN - SCOPUS:85127480187
SN - 1664-3224
VL - 13
JO - Frontiers in Immunology
JF - Frontiers in Immunology
M1 - 773191
ER -